[ TP Therapeutics raises $45M in Series C funding ]

TP Therapeutics has raised $45 million in Series C funding.

Founded in 2013, TP Therapeutics  is a structure-based drug design pharmaceutical company founded by Dr. J. Jean Cui, the lead inventor of Pfizer’s Xalkori(TM), the precision oncology drug for non-small cell lung cancer (NSCLC).

The company will use the fresh funding  to continue development of its lead program, TPX-0005, for treatment of naïve and resistant patients with ALK, ROS1 or NTRK abnormal genes and for the advancement of several pre-clinical pipeline projects.

Funding  Series C
Founded  2013
Country  USA
City  San Diego, California
Founder / CEO  Dr. Y. Peter Li
Deal Size  $45M
Investors  SV Tech Ventures
 SR One
 Lilly Asia Ventures
 OrbiMed
 Cormorant Asset Management
Previous Investors  /